More on DGX
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $234.91 |
|
|||
| Open | $236.00 | ||||
| 52 Wk High | $86.85 | ||||
| 52 Wk Low | $59.66 | ||||
| Day High | $237.29 | ||||
| Day Low | $234.06 | ||||
| P/E | 44.50 | ||||
| EPS | $5.31 | ||||
| Volume | 307,713 | ||||
- Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening Option
- Quest Diagnostics (DGX) PT Raised to $250 at UBS
- Current Screening Thresholds May Miss Half of Patients with Primary Aldosterone, a Leading Cause of Severe High Blood Pressure, Finds Study in Hypertension
- Quest Diagnostics (DGX) PT Raised to $260 at Barclays
- Form 8-K QUEST DIAGNOSTICS INC For: Oct 06
- Form 4 QUEST DIAGNOSTICS INC For: Oct 01 Filed by: WENTWORTH TIMOTHY C
- Haystack MRD® Demonstrates Robust Clinical Performance in Specimen Cohort from the Landmark DYNAMIC Colorectal Cancer Trials
- Quest Diagnostics to Release Third Quarter Financial Results on October 22, 2026
- Mizuho comments on DGX and LH post CMS on Monday
- Quest Diagnostics (DGX) PT Raised to $260 at Baird
Entities mentioned with DGX
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- FDA | View Related Stories »
- ARK | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Maynard Um | View Related Stories »
- Twitter | View Related Stories »
- Show More...
